Clinical Study of Dahuang Zhechong Pill (大黄Zhe虫丸) in Treating Posthepatitis B Hepatic Fibrosis
陈孝银, 李恩庆, 杨钦河, 章群, 孙立, 徐云生, 沈强
Abstract
陈孝银, 李恩庆, 杨钦河, 章群, 孙立, 徐云生, 沈强
Abstract
Hepatic fibrosis is the only way for all kinds of chronic hepatic diseases to develop into liver cirrhosis. How to block and reverse hepatic fibrosis is the key issue for treatment of all kinds of chronic hepatic disease. After many years arduous effort in treating hepatic fibrosis, no satisfactory results in western medical treatment have been obtained. Though hepatic fibrosis could be definitely reversed by colchicines, the strong toxicity of colchicines limited its clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Hepatic fibrosis is the only way for all kinds of chronic hepatic diseases to develop into liver cirrhosis. How to block and reverse hepatic fibrosis is the key issue for treatment of all kinds of chronic hepatic disease. After many years arduous effort in treating hepatic fibrosis, no satisfactory results in western medical treatment have been obtained. Though hepatic fibrosis could be definitely reversed by colchicines, the strong toxicity of colchicines limited its clinical application.
Key concepts: Hepatic fibrosis, Medicine, Chronic hepatic, Cirrhosis, Colchicine, Fibrosis, Gastroenterology, Internal medicine